drugset / Trial / NCT02625103
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
Phase 4
Completed
48 enrolled
Anders Fink-Jensen, MD, DMSci
Rigshospitalet, Denmark · collabUniversity of Copenhagen · collab
NaSingle-groupOpen-labelHealth-services research
Summary
The role of Therapeutic Drug Monitoring (TDM) in clozapine dose adjustment have been debated. Blood samples for s-clozapine monitoring should be drawn 12 hours post dose. The scope of this trial is to describe changes of s-clozapine and s-N-desmethyl-clozapine within the range of 10-14 hours after the last administration of clozapine .
Timeline
- Start
- 2015-09
- Primary completion
- 2015-12
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clozapine | Other / unclassified | — | — |